Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,294.9
0.0 (0.00%)

 

  • STI Straits Times Index
    3,294.9
    0.0 (0.00%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.1
    -0.7 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,965.5
    13.2 (0.05%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,522.6
    -32.5 (-0.91%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 805.0M
  • Value: 1,097.8M
  • Rise: 135
  • Fall: 158
  • Unch: 474

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.086+0.003
DISA0.009+0.001
ThaiBev0.660+0.005
The Place Hldg0.074+0.016
Geo Energy Res0.355+0.025
Sembcorp Marine0.083-
Arion Ent0.011+0.001
Singtel2.480+0.010
Oceanus0.029+0.001
Genting Sing0.775-0.005

World Indices

World Indices
Name Last Change
Nasdaq 13,768.9 -385.1
HSI 24,965.5 +13.2
HSCEI 8,787.3 +25.7
Jakarta 6,726.4 +99.5
Nikkei 225 27,522.3 -250.7
SSE Comp 3,522.6 -32.5
Shanghai A 3,691.5 -34.1
Shanghai B 286.2 -0.8
KOSPI 2,834.3 -28.4

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SAB BIOTHERAPEUTICS INC SAB BIOTHERAPEUTICS
Updated on 21 Jan 2022 (End of trading day)
Last (USD): 5.480 Change: -0.340 High: 5.920 Remarks: -
Change (%): -5.84 Low: 5.410
Open 5.920 Yesterday's Close 5.82
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 81,123 Cumulative Value

Company Background

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The company produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton and is headquartered in Sioux Falls, SD.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.00021 Trailing EPS (USD) b 0.00992 NAV (USD) c 2.4579
PE a - Trailing PE d 552.466 Price / NAV c 2.2295
Dividend Yield (%) e - Cash In Hand (USD) f 0.0154 Issued & Paid-up Shares g 43,474,800
Piotroski F Score - Market Cap (M) 238.242 Free Float (%) 57.6
Return on Equity (ROE) (%) h 0.404 Revenue Growth (%) TTM i n.a.
Net Earnings Growth (%) j n.a. Net Debt/Equity k Net Cash
Sector & Industry Finance - Financial Conglomerates
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 01 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.270
-18.81 %
10 Days --1.890
-25.64 %
20 Days --3.270
-37.37 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SAB BIOTHERAPEUTICS INC NASDAQ 238.242 - 552.466 2.2295 -
Industry Financial Conglomerates NASDAQ 300.391 308.871 323.376 1.8146 0.043
Local Peer ROIVANT SCIENCES LTD NASDAQ 5,017.087 - - 2.4617 -
Local Peer EXP WORLD HOLDINGS INC NASDAQ 3,660.393 117.583 49.843 19.4116 -
Local Peer CVENT HOLDING CORP NASDAQ 3,209.084 - - 12.1760 -
Local Peer DIGITAL WORLD ACQUISITION CORP NASDAQ 2,611.310 - - 9.1796 -
Local Peer DAVE INC NASDAQ 3,507.966 639.756 865.582 14.0223 -
Local Peer ARQIT QUANTUM INC NASDAQ 2,131.296 - - -62.5440 -
Local Peer RIOT BLOCKCHAIN INC NASDAQ 1,748.162 - 113.267 2.2695 -
Local Peer MARKETWISE INC NASDAQ 1,881.655 - - -32.2493 -
Local Peer CYXTERA TECHNOLOGIES INC NASDAQ 1,802.532 - - 2.7028 -
Local Peer FARADAY FUTURE INTELLIGENT ELEC INC NASDAQ 1,527.738 - - 6.9336 -
Local Peer SOMALOGIC INC NASDAQ 1,507.359 - - 2.4083 -
Local Peer SNAP ONE HLDNS CORP NASDAQ 1,377.391 - - 1.8336 -
Other Local Peers SOLID POWER INC (NASDAQ), P3 HEALTH PARTNERS INC (NASDAQ), NAVITAS SEMICONDUCTOR CORP (NASDAQ), GORES GUGGENHEIM INC (NASDAQ), SARCOS TECHNOLOGY & ROBOTICS CORP (NASDAQ), ROVER GROUP INC (NASDAQ), SCIENCE 37 HLDGS INC (NASDAQ), FTAC HERA ACQUISITION CORP (NASDAQ), PARDES BIOSCIENCES INC (NASDAQ), GREAT SOUTHERN BANCORPORATION INC (NASDAQ), CIPHER MNG INC (NASDAQ), CONX CORP (NASDAQ), TANGO THERAPEUTICS INC (NASDAQ), MSD ACQUISITION CORP (NASDAQ), DOCGO INC (NASDAQ), GORES HLDGS VII INC (NASDAQ), KHOSLA VENTURES ACQUISITION CO III (NASDAQ), CF ACQUISITION CORP IV (NASDAQ), INTERNATIONAL MONEY EXPRESS INC (NASDAQ), E MERGE TECHNOLOGY ACQUISITION CORP (NASDAQ), LANDCADIA HLDGS IV INC (NASDAQ), LIBERTY MEDIA ACQUISITION CORP (NASDAQ), SVF INVESTMENT CORP (NASDAQ), BRIDGETOWN HLDGS LTD (NASDAQ), HUDSON EXECUTIVE INVT CORP III (NASDAQ), SCION TECH GROWTH I (NASDAQ), SLAM CORP (NASDAQ), VECTOR ACQUISITION CORPORATION II (NASDAQ), REVOLUTION HEALTHCARE ACQUISITION C (NASDAQ), HEALTH ASSURANCE ACQUISITION CORP (NASDAQ), FTAC ZEUS ACQUISITION CORP (NASDAQ), GORES HOLDINGS IX INC (NASDAQ), DRAGONEER GROWTH OPPS CORP III (NASDAQ), WATERSTONE FINANCIAL INC MD (NASDAQ), WEST BANCORPORATION INC (NASDAQ), SENIOR CONNECT ACQUISITION CORP I (NASDAQ), MELI KASZEK PIONEER CORP (NASDAQ), CARNEY TECHNOLOGY ACQ CORP II (NASDAQ), EPIPHANY TECH ACQUISITION CORP (NASDAQ), TCV ACQUISITION CORP (NASDAQ), PIONEER MERGER CORP (NASDAQ), CORNER GROWTH ACQUISITION CORP (NASDAQ), TRINITY CAPITAL INC (NASDAQ), CF ACQUISITION CORP VI (NASDAQ), RMG ACQUISITION CORP III (NASDAQ), AEYE INC (NASDAQ), NORTH ATLANTIC ACQUISITION CORP (NASDAQ), GORES TECHNOLOGY PARTNERS II INC (NASDAQ), ADS TEC ENERGY PLC (NASDAQ), KHOSLA VENTURES ACQUISITION CO (NASDAQ), BURGUNDY TECHNOLOGY ACQUISITION COR (NASDAQ), RESERVOIR MEDIA INC (NASDAQ), ARTISAN ACQUISITION CORP (NASDAQ), CATALYST PARTNERS ACQUISITION CORP (NASDAQ), GORES HOLDINGS VIII INC (NASDAQ), INDEPENDENCE HOLDINGS CORP (NASDAQ), VECTOIQ ACQUISITION CORP II (NASDAQ), TWELVE SEAS INVESTMENT CO II (NASDAQ), NIGHTDRAGON ACQUISITION CORP (NASDAQ), FARMERS & MERCHANTS BANCORP INC (NASDAQ), POEMA GLOBAL HOLDINGS CORP (NASDAQ), QUEENS GAMBIT GROWTH CAPITAL (NASDAQ), WALDENCAST ACQUISITION CORP (NASDAQ), ANZU SPECIAL ACQUISITION CORP I (NASDAQ), ADTHEORENT HOLDING COMPANY INC (NASDAQ), LUX HEALTH TECH ACQUISITION CORP (NASDAQ), SILVER CREST ACQUISITION CORP (NASDAQ), HENNESSY CAPITAL INVESTMENT CORP V (NASDAQ), SCION TECH GROWTH II (NASDAQ), JACK CREEK INVESTMENT CORP (NASDAQ), THUNDER BRIDGE CAP PARTNERS III INC (NASDAQ), COLICITY INC (NASDAQ), MARBLEGATE ACQUISITION CORP (NASDAQ), ZIMMER ENERGY TRANSITION ACQ CORP (NASDAQ), LOGISTICS INNOVATION TECHNOLOGIES C (NASDAQ), MARLIN TECHNOLOGY CORPORATION (NASDAQ), HENNESSY CAP INVESTMENT CORP VI (NASDAQ), JOFF FINTECH ACQUISITION CORP (NASDAQ), ORION ACQUISITION CORP (NASDAQ), SVF INVESTMENT CORP 3 (NASDAQ), HEALTHCARE SERVICES ACQ CORP (NASDAQ), INFLECTION PT ACQUISITION CORP (NASDAQ), BYTE ACQUISITION CORP (NASDAQ), PROSPECTOR CAP CORP (NASDAQ), PATHFINDER ACQUISITION CORP (NASDAQ), FOUNDER SPAC (NASDAQ), DECARBONIZATION PLUS ACQ CORP IV (NASDAQ), ENJOY TECHNOLOGY INC (NASDAQ), PLUM ACQUISITION CORP I (NASDAQ), INTERNATIONAL GENERAL INS HLDGS LTD (NASDAQ), ARCLIGHT CLEAN TRANSITION CORP II (NASDAQ), TECH & ENERGY TRANSITION CORP